Enhancing the role of vaccines in combatting antimicrobial resistance
- PMID: 29153150
- PMCID: PMC5714609
- DOI: 10.1016/j.vaccine.2017.09.053
Enhancing the role of vaccines in combatting antimicrobial resistance
Abstract
Interest in addressing antimicrobial resistance (AMR) has grown recently but little effort has been made to consider how existing and new vaccines could impact on AMR. A 2017 Chatham House meeting considered the role of vaccines and how to demonstrate their value through their impact on AMR. Ways existing vaccines have reduced antibiotic prescribing and the prevalence of some resistant organisms were reviewed. Other new vaccines could have a similar impact. In gonorrhoea, where complete resistance has developed, vaccine may be the best option. Valuing the impact of vaccines on AMR was challenging: there were difficult methodological issues and a lack of data for modelling. A participant poll suggested priorities for accelerated vaccine development were tuberculosis, typhoid, influenza, RSV and gonorrhoea. More evidence is needed to convince policymakers but that vaccine development projects should be considered by funders on the same basis as those for new antibiotics or diagnostics.
Keywords: Antibiotics; Antimicrobial resistance; Vaccines; Valuation.
Copyright © 2017. Published by Elsevier Ltd.
References
-
- Boston Consulting Group, Federal Ministry of Health. Breaking through the Wall: a call for concerted action on antibiotics research and development. Berlin; 2017. <http://www.bcg.de/documents/file219507.pdf>.
-
- Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. London; 2016. <https://amr-review.org/sites/default/files/160525_Final%20paper_with%20c...>.
-
- Review on Antimicrobial Resistance. Vaccines and alternative approaches: reducing our dependence on antimicrobials. London; 2016. <https://amr-review.org/sites/default/files/Vaccines%20and%20alternatives...>.
-
- Chatham House. Meeting summary: the value of vaccines in the avoidance of antimicrobial resistance. London; 2017. https://www.chathamhouse.org/sites/files/chathamhouse/events/2017-03-30-....
-
- Tomczyk S. Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2016;62(9):1119–1125. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical